Name: ADMA Biologics, Inc. (ADMA) Financial Statements
Creator: FinSpry

ADMA Biologics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

ADMA Biologics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	426.45	258.22	154.08	80.94	42.22	29.35	16.99
Cost of Revenue	206.90	169.27	118.82	79.77	61.29	39.50	42.19
Gross Profit	219.55	88.94	35.27	1.17	-19.07	-10.16	-25.21
Operating Expenses
Research & Development	1.81	3.30	3.61	2.85	5.91	2.34	3.93
Selling, General & Administrative	78.37	59.02	52.46	55.19	35.05	25.91	22.50
Operating Expenses	80.57	67.31	74.63	58.75	45.84	31.27	35.08
Operating Income	138.98	21.63	-39.37	-57.57	-64.91	-41.42	-60.29
Other Income/Expense
Interest Income	2.10	1.62	0.05	0.04	0.29	0.00	0.20
Interest Expense	-13.93	25.03	19.28	-13.06	-11.99	0.00	5.52
Other Income/Expense	-0.19	26.46	-7.31	-0.25	-0.86	10.19	-0.13
Income
Income Before Tax	125.71	-28.24	-65.90	-71.65	-75.75	-48.28	-65.74
Income Tax Expense	-71.96	-0.76	-1.77	-0.25	-3.80	-0.47	0.00
Net Income	197.67	-28.24	-65.90	-71.65	-75.75	-48.28	-65.74
Net Income - Continuous Operations	197.67	-28.24	-65.90	-71.65	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	147.03	-18.22	-39.51	-52.08	-59.82	-45.26	-56.77
EBIT	138.98	-29.00	-46.63	-57.57	-63.76	-49.55	-60.22
Depreciation & Amortization	8.05	0.70	0.72	5.50	0.72	0.84	0.84
Earnings Per Share
Basic EPS	1.00	-	-	-1.00	-1.00	-	-1.00
Diluted EPS	1.00	-	-	-1.00	-1.00	-1.00	-1.00
Basic Shares Outstanding	233.08	223.98	197.87	139.58	86.15	54.35	45.19
Diluted Shares Outstanding	243.34	223.98	197.87	139.58	86.15	54.35	45.19